Regeneron Is Just Getting Started (NASDAQ:REGN)
· seekingalpha.com
Regeneron enters a new growth cycle after a strong Q3, with Dupixent, Eylea HD, and pipeline momentum boosting the outlook. Read this analysis on REGN here.
I publish my best ideas and top coverage on the Growth Stock Forum. If you're interested in finding great growth stocks, with a focus on biotech, consider signi...